```html

Fistula‑in‑Ano – Comprehensive Medical Guide

Overview

A fistula‑in‑ano (anal fistula) is an abnormal tunnel‑like connection that forms between the anal canal (or rectum) and the skin surrounding the anus. The tract typically begins as an infected anal gland that bursts through the internal sphincter muscle, creating a passage that can drain pus or stool onto the perianal skin.

Although it can occur at any age, fistula‑in‑ano is most common in young to middle‑aged adults (20‑50 years) and is slightly more prevalent in men than women (about 1.5:1). In the United States, roughly 2–3 per 10,000 people develop an anal fistula each year, representing about 8‑10 % of all anorectal disorders seen in colorectal clinics.<sup>1</sup>

Symptoms

Symptoms may be mild at first and progress over weeks or months. Common manifestations include:

• Pain or discomfort around the anal margin, especially during bowel movements or prolonged sitting.
• Continuous or intermittent drainage of clear fluid, mucus, pus, or even fecal material from a small opening (the external opening) near the anus.
• Swelling or a palpable lump near the anus that can become tender or warm.
• Itching (pruritus) and irritation caused by wetness from drainage.
• Bleeding – less common, but may occur if the tract erodes into a blood vessel.
• Fever or chills if an infection spreads (sign of an abscess).
• Recurrent abscesses – many patients experience a painful perianal abscess before a fistula forms.
• Difficulty controlling gas or stool if the tract interferes with the sphincter muscles.

Causes and Risk Factors

Primary cause

The majority of anal fistulas (≈85 %) arise from a cryptoglandular infection—an infection of the small anal glands (crypts) that line the dentate line. When the gland becomes blocked, pus builds up, forming an abscess that can burst, creating a tract.

Other contributing conditions

• Inflammatory bowel disease (IBD) – Crohn’s disease or ulcerative colitis increases fistula risk (up to 30 % of Crohn’s patients develop perianal fistulas).<sup>2</sup>
• Trauma – surgical procedures, childbirth, or penetrating injuries to the perianal region.
• Radiation therapy to the pelvis can damage tissue, predisposing to fistula formation.
• Sexually transmitted infections (e.g., HIV, syphilis) that compromise immunity.
• Tuberculosis of the gastrointestinal tract (rare in high‑income countries).

Risk factors

• Male sex
• Age 20‑50 years
• History of perianal abscess
• Chronic constipation or frequent diarrhea (causes repeated strain)
• Obesity (higher intra‑abdominal pressure)
• Immunosuppression (e.g., steroids, HIV, chemotherapy)
• Active IBD, especially Crohn’s disease

Diagnosis

Accurate diagnosis is essential because the fistula’s anatomy determines the optimal treatment. A combination of history, physical exam, and imaging is used.

Clinical examination

• Digital rectal exam (DRE) – the clinician gently inserts a gloved finger to feel the internal opening and assess sphincter integrity.
• Inspection – the external opening is visualized; gentle probing with a blunt, sterile instrument can delineate the tract.
• Seton placement – a thin thread may be briefly introduced to help map the fistula.

Imaging studies

• Endoanal or endorectal ultrasound – high‑frequency probe provides real‑time images of the sphincter layers.
• Magnetic resonance imaging (MRI) – gold standard for complex fistulas; shows the primary tract, branches, and relation to sphincters.
• Contrast fistulography – rarely used now, involves injecting contrast into the external opening and taking X‑rays.
• Computed tomography (CT) scan – helpful when an abscess or pelvic sepsis is suspected.

Laboratory tests are not diagnostic but may be ordered to rule out infection (CBC) or to assess underlying IBD (CRP, ESR, stool studies).

Treatment Options

Management aims to eradicate the tract while preserving continence. Treatment choice depends on fistula type (simple vs. complex), patient health, and surgeon expertise.

Medical management

• Antibiotics – short courses (e.g., metronidazole 500 mg PO TID for 7‑10 days) may be used for acute infection or pre‑operative preparation but do not close the fistula.
• Immunomodulators for Crohn’s‑related fistulas – agents such as azathioprine, infliximab, or adalimumab have shown fistula‑healing rates of 30‑50 %.<sup>3</sup>

Surgical procedures

Nearly all persistent fistulas require an operation. The main categories are:

1. Seton placement (drainage seton)

• A loop of non‑absorbable suture or rubber tube is left in the tract to keep it open, allowing drainage and preventing abscess formation.
• Used as a bridge to definitive surgery, especially in high‑risk (complex) fistulas or in Crohn’s disease.

2. Fistulotomy (lay‑open)

• The tract is surgically opened and laid flat to heal by secondary intention.
• Best for simple low fistulas that involve < 30 % of the external sphincter.
• Success rate ≈ 85‑95 % with low continence disturbance.

3. Advancement flap repair

• After excising the internal opening, a flap of rectal mucosa or muscle is mobilized and sutured over the defect.
• Ideal for mid‑level or high fistulas where sphincter preservation is critical.
• Healing rates 60‑80 %.

4. Ligation of intersphincteric fistula tract (LIFT)

• The intersphincteric portion of the fistula is ligated and divided.
• Minimally invasive, preserves sphincter function, and shows 70‑80 % success in systematic reviews.

5. Video‑assisted anal fistula treatment (VAAFT)

• Endoscopic technique using a fistuloscope to visualize and cauterize the tract from the inside out.
• Reported healing 65‑80 % with low recurrence.

6. Fibrin glue or plug

• Biological adhesives or bio‑absorbable plugs are inserted into the tract to seal it.
• Less invasive, but variable success (30‑60 %).

7. Stem‑cell therapy (research/clinical trials)

• Autologous adipose‑derived mesenchymal stem cells have shown promising closure rates in Crohn’s‑related fistulas (≈ 70 %).
• Still investigational and not widely available.

Post‑operative care & lifestyle

• High‑fiber diet (25‑35 g/day) to ensure soft stools.
• Stool softeners (e.g., polyethylene glycol) for 2‑3 weeks post‑operatively.
• Warm sitz baths 2‑3 times daily for 10‑15 minutes to promote healing.
• Avoid heavy lifting or prolonged sitting for 4‑6 weeks after surgery.
• Follow‑up appointments at 2 weeks, 6 weeks, and 3 months to monitor healing.

Living with Fistula‑in‑Ano

Daily management tips

• Hygiene – Gently clean the perianal area with warm water after each bowel movement; pat dry or use a soft towel. Avoid harsh soaps.
• Dressings – Use absorbent, breathable pads (e.g., gauze with a moisture‑wicking layer) to keep the wound dry and protect clothing.
• Diet – Increase fiber (fruits, vegetables, whole grains) and hydrate (≥ 2 L water/day) to prevent constipation.
• Exercise – Light walking promotes bowel regularity; avoid cycling or rowing until the tract is fully healed.
• Stress reduction – Chronic stress can worsen IBD; consider yoga, meditation, or counseling.
• Track symptoms – Keep a diary of drainage amount, pain scores, and bowel habits to discuss with your clinician.

Psychosocial aspects

The presence of an external opening can cause embarrassment and impact quality of life. Seeking support from a therapist, joining a patient support group, or speaking with a colorectal nurse specialist can be enormously helpful.

Prevention

While not all fistulas are preventable, risk can be reduced by:

• Maintaining regular, soft bowel movements through high‑fiber diet and adequate fluids.
• Prompt treatment of perianal abscesses – early drainage reduces the chance of a chronic fistula.
• Managing underlying conditions such as Crohn’s disease with appropriate medication and follow‑up.
• Practicing good perianal hygiene and avoiding chronic irritation (e.g., over‑vigorous wiping).
• Weight management to lower intra‑abdominal pressure.
• Avoiding smoking – it impairs wound healing and worsens Crohn’s disease.

Complications

If left untreated or inadequately treated, fistula‑in‑ano may lead to:

• Recurrent perianal abscesses – painful collections that may require repeated drainage.
• Chronic drainage causing skin maceration, ulceration, and secondary infection.
• Anal sphincter damage – leading to fecal incontinence, especially after aggressive surgery.
• Spread of infection – sepsis, cellulitis, or even fistulous extension into the pelvis or vagina (rare).
• Malignancy – long‑standing chronic inflammation has a small (< 0.5 %) risk of squamous cell carcinoma of the fistulous tract.

When to Seek Emergency Care

References

1. Garg, P., & Mak, D. (2020). Anal fistula: a review of current management. World Journal of Gastrointestinal Surgery, 12(7), 587‑599. DOI:10.4240/wjgs.v12.i7.587
2. Mayo Clinic. Perianal fistulas. Retrieved May 2026, from https://www.mayoclinic.org
3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Crohn’s disease treatment. Retrieved May 2026, from https://www.niddk.nih.gov
4. World Health Organization. Global health estimates 2022. Retrieved May 2026.
5. Cleveland Clinic. Anal fistula – symptoms and treatment. Retrieved May 2026.

```